发明名称 |
METHODS AND COMPOSITIONS FOR MALIC ENZYME 2 (ME2) AS A TARGET FOR CANCER THERAPY |
摘要 |
The present invention relates to methods, compositions, and diagnostic tests for treating and diagnosing cancer and other related diseases that result in dysregulation of malic enzyme 2. In particular, the methods and compositions include combination therapy, such as with a combination of two or more ME2 inhibitors or a combination of an ME2 inhibitor and an anticancer agent. |
申请公布号 |
WO2012019154(A3) |
申请公布日期 |
2014.03.20 |
申请号 |
WO2011US46841 |
申请日期 |
2011.08.05 |
申请人 |
BETH ISRAEL DEACONESS MEDICAL CENTER;SUKHATME, VIKAS, P.;REN, JIAN-GUO |
发明人 |
SUKHATME, VIKAS, P.;REN, JIAN-GUO |
分类号 |
C12N15/113;A61K31/7088 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|